Management of bone metastases from advanced renal cell carcinoma

被引：1
|
作者：
Khattak, Muhammad Adnan [1 ]
Martin, Hilary Laura [1 ]
机构：
[1] Royal Marsden NHS Trust, London SW3 6JJ, England
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷 / 16期
关键词：
SKELETAL-RELATED EVENTS; LONG-TERM EFFICACY; ZOLEDRONIC ACID; PREVENTIVE MEASURES; MULTIPLE-MYELOMA; BREAST-CANCER; DOUBLE-BLIND; OSTEONECROSIS; COMPLICATIONS; JAW;
D O I：
10.1016/j.ejca.2012.05.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3123 / 3125
页数：3
相关论文
共 50 条
  • [31] Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
    Hilton, J. F.
    Clemons, M.
    Pond, G.
    Zhao, H.
    Mazzarello, S.
    Vandermeer, L.
    Addison, C. L.
    JOURNAL OF BONE ONCOLOGY, 2018, 10 : 6 - 13
  • [32] Prevention and Management of Bone Metastases in Lung Cancer A Review
    Al Husaini, Hamed
    Wheatley-Price, Paid
    Clemons, Mark
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 251 - 259
  • [33] Bone Metastases From Advanced Cancers: Clinical Implications and Treatment Options
    Fitch, Margaret
    Maxwell, Cathy
    Ryan, Claire
    Lothman, Helen
    Drudge-Coates, Lawrence
    Costa, Luis
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2009, 13 (06) : 701 - 710
  • [34] Efficacy of zoledronic acid in the treatment of bone metastases secondary to renal cell carcinoma
    Schulman, CC
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (05) : 40 - 45
  • [35] Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma
    Yosuke Yasuda
    Yasuhisa Fujii
    Takeshi Yuasa
    Shinichi Kitsukawa
    Shinji Urakami
    Shinya Yamamoto
    Junji Yonese
    Shunji Takahashi
    Iwao Fukui
    International Journal of Clinical Oncology, 2013, 18 : 877 - 883
  • [36] Epidemiology, management and cost of bone metastases from lung cancer
    Decroisette, C.
    Galerneau, L. -M.
    Hominal, S.
    Chouaid, C.
    REVUE DES MALADIES RESPIRATOIRES, 2013, 30 (04) : 309 - 315
  • [37] Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma
    Yasuda, Yosuke
    Fujii, Yasuhisa
    Yuasa, Takeshi
    Kitsukawa, Shinichi
    Urakami, Shinji
    Yamamoto, Shinya
    Yonese, Junji
    Takahashi, Shunji
    Fukui, Iwao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 877 - 883
  • [38] Evolving Role of Urologists in the Management of Advanced Renal Cell Carcinoma
    Kapoor, Anil
    Kim, Jaehoon
    Goucher, George
    Hoogenes, Jen
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (03) : 271 - 280
  • [39] Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom
    Botteman, M. F.
    Meijboom, M.
    Foley, I.
    Stephens, J. M.
    Chen, Y. M.
    Kaura, S.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2011, 12 (06) : 575 - 588
  • [40] Renal cell carcinoma with gastric metastases
    Hanane Inrhaoun
    Ibrahim Elghissassi
    Maya Gutierrez
    Hassan Errihani
    Emmanuel Mitry
    Journal of Gastrointestinal Cancer, 2012, 43 (Suppl 1) : S181 - S183
12345